Search results
- Nano-X's device may be able to produce X-rays at a lower cost than traditional sources, but the company still hasn't found a way to turn Nanox.ARC into a sustainable business. It's probably best to keep this stock on a watchlist, not in your portfolio, until after it can demonstrate profitability.
www.fool.com/investing/2024/05/30/down-is-nano-x-imaging-a-buy-on-the-dip/Down 53%. Is Nano-X Imaging a Buy on the Dip? - The Motley Fool
People also ask
Is Nano-X imaging (nnox) stock up or down?
Is Nano-X imaging teaming up with Nvidia?
What is Nano-X imaging?
Is Nano-X stock a risky bet?
What happened to nnox imaging stock?
Did Nvidia buy Nano-X imaging (nnox) in February?
Feb 29, 2024 · According to a recent regulatory filing, chipmaker (NASDAQ: NVDA) now owns a stake in (NASDAQ: NNOX), a small Israeli medical device company that makes X-ray machines. While the investment was...
Oct 2, 2021 · Israeli technology company Nano-X Imaging(NNOX -1.84%) says its low-cost X-ray machine and razor-and-blades business model could revolutionize the field of radiology. But investing in...
Apr 5, 2021 · Among the three analysts tracking NNOX, two recommend a buy and one recommends a hold. None of the analysts recommend a sell. The highest target price of $67 is 62 percent above the stock's ...
- What Happened
- So What
- Now What
Nano-X (NNOX-3.02%)rose more than 16% on Wednesday. The stock opened at $23.66, then climbed to as high as $28.60 in mid-afternoon trading. The stock is still a lot closer to its 52-week low of $19.05 than its 52-week high of $94.81. Nano-X, which went public with an initial public offering in August of 2020, is down more than 38% for the year, but...
This was purely a retail-investor push. The stock, which has the potential to be a disruptive force with its low-cost commercial grade digital x-ray system, didn't have any news to announce and its next earnings report isn't until Nov. 17. The key for Nano-X is getting Food and Drug Administration (FDA) clearance for its multi-source imaging system...
Nano-X, while it could be a big disruptive force in healthcare, doesn't yet have a marketed product and because of that, isn't yet profitable. It lost $13.6 million in the second quarter, but it does have $193.4 million in cash. There's obviously a lot of risk here. Not only does Nano-X need FDA clearance for its multi-source machine, it also has t...
Apr 6, 2021 · Shares of Nano-X Imaging (NASDAQ: NNOX) jumped 17.47% on Monday after the U.S. Food and Drug Administration (FDA) gave the company's single-source digital imaging system 510 (k) clearance on...
Mar 6, 2024 · Should you invest $1,000 in Nano-X Imaging right now? Before you buy stock in Nano-X Imaging, consider this:
Mar 5, 2021 · Nano-X Imaging Ltd. (NASDAQ: NNOX) has developed an alternative x-ray solution to replace traditional analog high-voltage filament heated systems which are currently the standard on the...
